{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:46:14Z","timestamp":1792640774478,"version":"4.5.0"},"reference-count":32,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NU21-01-00448"],"award-info":[{"award-number":["NU21-01-00448"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["Institute of Endocrinology \u2013 E\u00da, 00023761"],"award-info":[{"award-number":["Institute of Endocrinology \u2013 E\u00da, 00023761"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Chromosomal rearrangements of NTRK genes are oncogenic driver mutations in thyroid cancer (TC). This study aimed to identify NTRK fusion-positive thyroid tumors and to correlate them with clinical and pathological data and determine their prognostic significance. The cohort consisted of 989 different TC samples. Based on the detected mutation, samples were triaged, and those that were positive for a BRAF, HRAS, KRAS, NRAS, RET, RET\/PTC or PAX8\/PPAR\u03b3 mutation were excluded from further analyses. NTRK fusion gene testing was performed in 259 cases, including 126 cases using next-generation sequencing. NTRK fusion genes were detected in 57 of 846 (6.7%) papillary thyroid carcinomas and in 2 of 10 (20.0%) poorly differentiated thyroid carcinomas. A total of eight types of NTRK fusions were found, including ETV6\/NTRK3, EML4\/NTRK3, RBPMS\/NTRK3, SQSTM1\/NTRK3, TPM3\/NTRK1, IRF2BP2\/NTRK1, SQSTM1\/NTRK1 and TPR\/NTRK1.NTRK fusion-positive carcinomas were associated with the follicular growth pattern, chronic lymphocytic thyroiditis and lymph node metastases. NTRK1-rearranged carcinomas showed a higher frequency of multifocality and aggressivity than NTRK3-rearranged carcinomas. Tumor size, presence of metastases, positivity for the NTRK3 or NTRK1 fusion gene and a late mutation event (TERT or TP53 mutation) were determined as factors affecting patient prognosis. NTRK fusion genes are valuable diagnostic and prognostic markers.<\/jats:p>","DOI":"10.3390\/cancers13081932","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T10:20:11Z","timestamp":1618568411000},"page":"1932","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["NTRK Fusion Genes in Thyroid Carcinomas: Clinicopathological Characteristics and Their Impacts on Prognosis"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8571-164X","authenticated-orcid":false,"given":"Barbora","family":"Pekova","sequence":"first","affiliation":[{"name":"Department of Molecular Endocrinology, Institute of Endocrinology, 11694 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3449-1472","authenticated-orcid":false,"given":"Vlasta","family":"Sykorova","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology, Institute of Endocrinology, 11694 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Mastnikova","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology, Institute of Endocrinology, 11694 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliska","family":"Vaclavikova","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology, Institute of Endocrinology, 11694 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitka","family":"Moravcova","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology, Institute of Endocrinology, 11694 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Vlcek","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Endocrinology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, 15006 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Lastuvka","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology and Head and Neck Surgery, 1st Faculty of Medicine, Charles University and Motol University Hospital, 15006 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milos","family":"Taudy","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology and Head and Neck Surgery, 1st Faculty of Medicine, Charles University and Motol University Hospital, 15006 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8503-1348","authenticated-orcid":false,"given":"Rami","family":"Katra","sequence":"additional","affiliation":[{"name":"Department of Ear, Nose and Throat, 2nd Faculty of Medicine, Charles University and Motol University Hospital, 15006 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Bavor","sequence":"additional","affiliation":[{"name":"Department of Surgery, 2nd Faculty of Medicine, Charles University and Motol University Hospital, 15006 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Kodetova","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine, Charles University and Motol University Hospital, 15006 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9087-0269","authenticated-orcid":false,"given":"Martin","family":"Chovanec","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Charles University, 3rd Faculty of Medicine, University Hospital Kralovske Vinohrady, 10034 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Drozenova","sequence":"additional","affiliation":[{"name":"Department of Pathology, Charles University, 3rd Faculty of Medicine, University Hospital Kralovske Vinohrady, 10034 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8022-0200","authenticated-orcid":false,"given":"Jaromir","family":"Astl","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology and Maxillofacial Surgery, Military University Hospital, 16902 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Hrabal","sequence":"additional","affiliation":[{"name":"Department of Pathology, Military University Hospital, 16902 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Vcelak","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology, Institute of Endocrinology, 11694 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7008-8675","authenticated-orcid":false,"given":"Bela","family":"Bendlova","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology, Institute of Endocrinology, 11694 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00268-018-4479-z","article-title":"Overall Survival of Papillary Thyroid Carcinoma Patients: A Single-Institution Long-Term Follow-Up of 5897 Patients","volume":"42","author":"Ito","year":"2018","journal-title":"World J. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/jamaoto.2015.2332","article-title":"Aggressive Palliation and Survival in Anaplastic Thyroid Carcinoma","volume":"141","author":"Nachalon","year":"2015","journal-title":"JAMA Otolaryngol. Neck Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1007\/s00268-020-05521-2","article-title":"BRAFV600E Mutation is Associated with an Increased Risk of Papillary Thyroid Cancer Recurrence","volume":"44","author":"Enumah","year":"2020","journal-title":"World J. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Li, X., and Kwon, H. (2020). The Impact of BRAF Mutation on the Recurrence of Papillary Thyroid Carcinoma: A Meta-Analysis. Cancers, 12.","DOI":"10.3390\/cancers12082056"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12020-019-02117-2","article-title":"Association between TERT promoter mutations and clinical behaviors in differentiated thyroid carcinoma: A systematic review and meta-analysis","volume":"67","author":"Yang","year":"2019","journal-title":"Endocrine"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-016-0559-9","article-title":"Clinical utility of RAS mutations in thyroid cancer: A blurred picture now emerging clearer","volume":"14","author":"Xing","year":"2016","journal-title":"BMC Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1158\/2159-8290.CD-14-0765","article-title":"TRKing Down an Old Oncogene in a New Era of Targeted Therapy","volume":"5","author":"Vaishnavi","year":"2014","journal-title":"Cancer Discov."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41379-019-0324-7","article-title":"NTRK fusion detection across multiple assays and 33,997 cases: Diagnostic implications and pitfalls","volume":"33","author":"Solomon","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1530\/EJE-18-0653","article-title":"Targetable gene fusions identified in radioactive iodine refractory advanced thyroid carcinoma","volume":"180","author":"Garcia","year":"2019","journal-title":"Eur. J. Endocrinol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated Genomic Characterization of Papillary Thyroid Carcinoma","volume":"159","author":"Agrawal","year":"2014","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s12022-020-09648-9","article-title":"Detection of NTRK1\/3 Rearrangements in Papillary Thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing","volume":"31","author":"Lee","year":"2020","journal-title":"Endocr. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/path.5005","article-title":"Genetic landscape of papillary thyroid carcinoma in the Chinese population","volume":"244","author":"Liang","year":"2018","journal-title":"J. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1089\/thy.2019.0802","article-title":"RET, NTRK, ALK, BRAF, and MET Fusions in a Large Cohort of Pediatric Papillary Thyroid Carcinomas","volume":"30","author":"Pekova","year":"2020","journal-title":"Thyroid"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2350\/15-07-1667-OA.1","article-title":"Molecular Characterization of Sporadic Pediatric Thyroid Carcinoma with the DNA\/RNA ThyroSeq v2 Next-Generation Sequencing Assay","volume":"19","author":"Picarsic","year":"2016","journal-title":"Pediatr. Dev. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/cncr.29887","article-title":"NTRKfusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States","volume":"122","author":"Prasad","year":"2016","journal-title":"Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1470-2045(19)30856-3","article-title":"Larotrectinib in patients with TRK fusion-positive solid tumours: A pooled analysis of three phase 1\/2 clinical trials","volume":"21","author":"Hong","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1530\/EC-19-0069","article-title":"Somatic genetic alterations in a large cohort of pediatric thyroid nodules","volume":"8","author":"Pekova","year":"2019","journal-title":"Endocr. Connect."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000468519","article-title":"European Thyroid Association Guidelines regarding Thyroid Nodule Molecular Fine-Needle Aspiration Cytology Diagnostics","volume":"6","author":"Paschke","year":"2017","journal-title":"Eur. Thyroid J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/PAS.0000000000000814","article-title":"Clinical and Morphologic Features of ETV6-NTRK3 Translocated Papillary Thyroid Carcinoma in an Adult Population Without Radiation Exposure","volume":"41","author":"Seethala","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/cncr.28484","article-title":"ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer","volume":"120","author":"Bs","year":"2014","journal-title":"Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/cncy.22353","article-title":"Fine-needle aspiration cytomorphology of papillary thyroid carcinoma withNTRKgene rearrangement from a case series with predominantly indeterminate cytology","volume":"128","author":"Prasad","year":"2020","journal-title":"Cancer Cytopathol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Fazeli, S., Dadu, R., Waguespack, S.G., Sherman, S.I., Busaidy, N.L., Hu, M.I., Jimenez, C., Habra, M.A., Williams, M., and Altameemi, L. (2020). MON-491 TRK-Fusion Thyroid Cancer: A Clinical Overview in a Large Population at a Single Cancer Center. J. Endocr. Soc., 4.","DOI":"10.1210\/jendso\/bvaa046.328"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/gcc.22737","article-title":"NovelTG-FGFR1andTRIM33-NTRK1transcript fusions in papillary thyroid carcinoma","volume":"58","author":"Pfeifer","year":"2019","journal-title":"Genes Chromosom. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/s41379-020-0574-4","article-title":"Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC)","volume":"33","author":"Chu","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41379-018-0118-3","article-title":"Molecular characterization of cancers with NTRK gene fusions","volume":"32","author":"Gatalica","year":"2019","journal-title":"Mod. Pathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1038\/s41379-020-0638-5","article-title":"Clinicopathologic features of kinase fusion-related thyroid carcinomas: An integrative analysis with molecular characterization","volume":"33","author":"Chu","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1089\/thy.2020.0086","article-title":"Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases","volume":"30","author":"Xu","year":"2020","journal-title":"Thyroid"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1530\/EJE-15-0605","article-title":"ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome","volume":"174","author":"Tavares","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1634\/theoncologist.2016-0279","article-title":"Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions","volume":"22","author":"Borre","year":"2017","journal-title":"Oncologist"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/his.13942","article-title":"Mutational profiling of poorly differentiated and anaplastic thyroid carcinoma by the use of targeted next-generation sequencing","volume":"75","author":"Duan","year":"2019","journal-title":"Histopathology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11523-018-0590-1","article-title":"TRK Inhibition: A New Tumor-Agnostic Treatment Strategy","volume":"13","author":"Kummar","year":"2018","journal-title":"Target. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/8\/1932\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:48:58Z","timestamp":1760161738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/8\/1932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,16]]},"references-count":32,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["cancers13081932"],"URL":"https:\/\/doi.org\/10.3390\/cancers13081932","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,16]]}}}